119 related articles for article (PubMed ID: 18596672)
1. The impact of genomics in understanding human melanoma progression and metastasis.
Ren S; Liu S; Howell P; Xi Y; Enkemann SA; Ju J; Riker AI
Cancer Control; 2008 Jul; 15(3):202-15. PubMed ID: 18596672
[TBL] [Abstract][Full Text] [Related]
2. New Perspectives of "omics" Applications in Melanoma Research.
Rodríguez-Cerdeira C; Molares-Vila A
Open Biochem J; 2011; 5():60-6. PubMed ID: 22253648
[TBL] [Abstract][Full Text] [Related]
3. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
Tímár J; Gyorffy B; Rásó E
Clin Exp Metastasis; 2010 Aug; 27(6):371-87. PubMed ID: 20177751
[TBL] [Abstract][Full Text] [Related]
4. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
5. Genetic progression of metastatic melanoma.
Rodolfo M; Daniotti M; Vallacchi V
Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
[TBL] [Abstract][Full Text] [Related]
6. Integrative genome comparison of primary and metastatic melanomas.
Kabbarah O; Nogueira C; Feng B; Nazarian RM; Bosenberg M; Wu M; Scott KL; Kwong LN; Xiao Y; Cordon-Cardo C; Granter SR; Ramaswamy S; Golub T; Duncan LM; Wagner SN; Brennan C; Chin L
PLoS One; 2010 May; 5(5):e10770. PubMed ID: 20520718
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in human melanoma.
Howell PM; Liu S; Ren S; Behlen C; Fodstad O; Riker AI
Cancer Control; 2009 Jul; 16(3):200-18. PubMed ID: 19556960
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
9. Loss of MDA-7 expression with progression of melanoma.
Ellerhorst JA; Prieto VG; Ekmekcioglu S; Broemeling L; Yekell S; Chada S; Grimm EA
J Clin Oncol; 2002 Feb; 20(4):1069-74. PubMed ID: 11844832
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of melanomagenesis and the metastatic phenotype.
Crowson AN; Magro C; Miller A; Mihm MC
Semin Oncol; 2007 Dec; 34(6):476-90. PubMed ID: 18083371
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
12. High expression of DNA repair pathways is associated with metastasis in melanoma patients.
Kauffmann A; Rosselli F; Lazar V; Winnepenninckx V; Mansuet-Lupo A; Dessen P; van den Oord JJ; Spatz A; Sarasin A
Oncogene; 2008 Jan; 27(5):565-73. PubMed ID: 17891185
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
Winnepenninckx V; van den Oord JJ
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
[TBL] [Abstract][Full Text] [Related]
14. The promise of microarray technology in melanoma care.
Kim CJ; Reintgen DS; Yeatman TJ
Cancer Control; 2002; 9(1):49-53. PubMed ID: 11907466
[TBL] [Abstract][Full Text] [Related]
15. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
[TBL] [Abstract][Full Text] [Related]
16. Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers?
Branca M; Orso S; Molinari RC; Xu H; Guerrier S; Zhang Y; Mili N
Melanoma Res; 2018 Feb; 28(1):21-29. PubMed ID: 29194095
[TBL] [Abstract][Full Text] [Related]
17. Melanoma progression, gene expression and DNA microarrays.
Hoek KS
G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
[TBL] [Abstract][Full Text] [Related]
18. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.
Villares GJ; Zigler M; Bar-Eli M
Oncotarget; 2011; 2(1-2):8-17. PubMed ID: 21378407
[TBL] [Abstract][Full Text] [Related]
20. Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma.
Trent JM; Bittner M; Zhang J; Wiltshire R; Ray M; Su Y; Gracia E; Meltzer P; De Risi J; Penland L; Brown P
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():33-40. PubMed ID: 9020934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]